Virtu Financial LLC Trinity Biotech PLC Transaction History

Virtu Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 15, 2023	SELL	$0.98 - $6.15 $2,199 - $13,800	-2,244 Reduced 15.34%	12,381 $12,000
Q3 2022 Nov 07, 2022	BUY	$1.09 - $5.45 $15,941 - $79,706	14,625 New	14,625 $16,000
Q2 2022 Aug 09, 2022	SELL	$0.96 - $1.44 $36,408 - $54,613	-37,926 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.92 - $1.44 $34,891 - $54,613	37,926 New	37,926 $40,000
Q1 2021 May 19, 2021	SELL	$3.26 - $6.64 $97,467 - $198,522	-29,898 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$1.95 - $4.77 $8,502 - $20,797	4,360 Added 17.07%	29,898 $114,000
Q3 2020 Dec 11, 2020	BUY	$1.68 - $3.17 $42,903 - $80,955	25,538 New	25,538 $51,000
Q4 2018 Jan 16, 2019	SELL	$2.14 - $4.26 $72,269 - $143,864	-33,771 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$3.76 - $5.08 $126,978 - $171,556	33,771 New	33,771 $135,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $29M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.